Sloan Sheldon sold SYRE
May 1, 2026 · Form 4 insider transaction
Sloan Sheldon sold 400 shares of Spyre Therapeutics, Inc. at $75.37 per share, a transaction worth $30.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
400
Price
$75.37
Total value
$30.1K
InsiderSloan Sheldon
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 1, 2026
Filing dateMay 1, 2026
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.